Dr Anand Shah

Dr Anand Shah is a consultant respiratory physician based at the Royal Brompton Hospital. He has expertise in infection, particularly fungal lung infection including the following: Respiratory infection Fungal lung infection (including aspergillosis) Host defence abnormalities Bronchiectasis COVID-19 (infection and long-COVID) Cystic fibrosis Primary ciliary dyskinesia Primary or secondary immunodeficiency Non-tuberculous mycobacteria. Asthma and Allergic Bronchopulmonary Aspergillosis Dr Shah qualified with his medical degree from Imperial College London before training in respiratory medicine. He spent time within the lung transplant unit at Harefield Hospital as well as the Host Defence Unit at the Royal Brompton Hospital where he developed an interest in fungal lung infection. In 2011, he was awarded an MRC clinical research training Fellowship which enabled him to investigate susceptibility to fungal infection in solid organ transplantation at Imperial College London. His work earned him a PhD and a number of publications. He then became a consultant at Royal Brompton and Harefield NHS Foundation Trust in 2016 in the respiratory infection unit looking after ~2000 patients with complex respiratory infection. He leads the fungal clinical service which is one the largest complex lung fungal patient services in Europe. Dr Shah continues to be involved in research, and he focuses particularly on improving outcomes in bronchiectasis, respiratory infection with a particular focus on antimicrobial resistance and fungal lung disease. He is also an honorary clinical senior lecturer at Imperial College London with an active translational research laboratory where he supervises a number of PhD students and leads multiple national and international research programmes. He is a co-director of the Imperial College Fungal research network of excellence and chairs the European Respiratory Society Antimicrobial Resistance Lung network (AMR-Lung) with over 300 members across 60 countries. During his career, he has received a number of awards including the MRC Clinical Academic Research Partnership award (2019), the Cystic Fibrosis Mentored Research Innovation Award (2018), and the Gilead UK Fellowship in Invasive Fungal Infection (2017). Examples of current active research projects led by Dr Anand Shah: 1) BARRIER - Chief investigator of a £2 million MRC experimental medicine programme grant developing a novel human rhinovirus challenge model in bronchiectasis  2) PRIVILEGE - Chief investigator of a longitudinal cohort study in bronchiectasis to better understand causes of exacerbations and identify novel treatment strategies 3) PRESIDE - Chief investigator of international study of antimicrobial resistance in chronic lung disease

Respiratory infection Fungal lung infection (including aspergillosis) Host defence abnormalities Bronchiectasis COVID-19 (infection and long-COVID) Cystic fibrosis Primary ciliary dyskinesia Primary or secondary immunodeficiency Non-tuberculous mycobacteria. Asthma and Allergic Bronchopulmonary Aspergillosis